The TOPAZ Study is evaluating the safety and efficacy of an investigational medicine, compared to a placebo (an inactive substance that looks like and is administered in the same way as the investigational medicine) in people with active systemic lupus erythematosus (SLE) while taking their prescribed lupus treatment.
For those still experiencing symptoms, even with medication participating in the TOPAZ study may be an option.
The TOPAZ study is for people who are 18 years or older, have been diagnosed with moderate to severe systemic lupus erythematosus (SLE) for at least 6 months, and are currently receiving non-biologic SLE treatment.
Locations to participate in this study:
1. Royal Prince Alfred Hospital, Camperdown NSW 2050
2. Box Hill Hospital, Box Hill VIC 3128
3. Fiona Stanley Hospital, Murdoch WA 6150
If you reside in NSW and are interested in the TOPAZ study, please complete a short survey to check if you might be eligible: